HIV/AIDS Therapy

Epithelial permeability of phosphoramidate triester d4T prodrugs evaluated

Published in Cancer Weekly, February 24th, 2004

Epithelial permeability has been evaluated in a series of novel stavudine prodrugs.

"Nucleoside analogs are successful, widely used antiviral and anticancer therapeutics," scientists in Wales explained. "Nucleotide prodrugs (i.e, pronucleotide) have increasingly been used to improve in vivo efficacy of nucleoside analogs."

In a recent study, D. Siccardi and colleagues at the University of Wales "evaluated the permeability of a series of phosphoramidate triester prodrugs of the anti-HIV drug 2', 3'-didehydro-2', 3'-dideoxythymidine across monolayers of Caco-2, Madin-Darby canine kidney (MDCKII) epithelial cell line, and its recombinant clone...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-02-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry